Skip to main content

Ariadne, OU Team Up to Offer Cancer-Related Pathway Collection

NEW YORK (GenomeWeb News) — Ariadne Genomics said today that it has partnered with the University of Oklahoma to develop a cancer-related pathways collection.
 
The collection will then become available to Ariadne customers as an add-on to its pathway-analysis product line, according to the company.
 
The University of Oklahoma has already deployed Ariadne’s Pathway Studio software tool to develop a collection of cancer-related pathways.
 
Dee Wu, associate professor at the OU Health Sciences Center, said that the university will “perform scientific evaluation of pathway expansion and microarray data analysis algorithms available in Pathway Studio” in order to “build up a collection of cancer-related pathways using its built-in ResNet database and advanced pathway reconstruction and literature mining tools.”
 
Financial details were not discussed.

Filed under

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.